Metformin is a medication commonly prescribed for type two diabetics. Metformin is also sold as Glucophage, Fortamet, and Glumetza. A recent study in the scientific research journal of the Brazilian medical association found a high prevalence of vitamin B12 deficiency in Metformin treated diabetic patients.
Vitamin B12 is a water soluble vitamin that is naturally present in foods such as fish, shellfish, poultry, milk, eggs and meat. Vitamin B12 is necessary proper function of your nervous system, the manufacture of red blood cells as well as to make DNA. Vitamin B12 is also associated with regulating Homocysteine levels which is associated with heart disease.
Symptoms associated with vitamin B12 deficiency include:
- feeling tired and weak
- tingling in the hands and feet
- trouble with balance and walking
- mood changes including depression
- weight loss.
- soreness of the tongue
- bleeding gums
- frequent bruising
- paleness of the skin.
Vitamin B12 levels are typically evaluated by serum or plasma analysis. This type of testing can be performed at any of your standard laboratories such as Quest Diagnostics and as such are readily available to patients in the United States .
Ten to thirty percent of those over 50 years of age suffer from a condition called atrophic gastritis. In atrophic gastritis, there are reduced levels of hydrochloric acid produced by the stomach. The consequence of this low hydrochloric acid production is diminished absorption of vitamin B12. Thus, if you are elderly and a diabetic taking metformin, the chances of your having a vitamin B12 deficiency increase.
Vegetarians, who by definition do not eat animal proteins, and are the most prevalent source of vitamin B12, and those with digestive disorders such as crohn's disease, also need to beware of possible B12 deficiency. Once again, this is especially true if coupled with being a diabetic was taking metformin.
If you're a diabetic and taking Metformin and feel that several of the signs and symptoms listed above pertain to you, contact your physician for a vitamin B12 analysis. Many physicians are not aware of the nutritional consequences of the medication they prescribe and therefore a visit to a functional medicine practitioner may be in order.
Firm agrees to refund to settle suit over weight-loss pills
SALT LAKE CITY (AP) — A Salt Lake City-based company has agreed to pay refunds to consumers who purchased its weight-loss tablets to settle a class-action lawsuit that claimed its advertising slogan, "Eat All You Want & Still Lose Weight," was deceptive.
Chile leader visits ailing 14 year-old who wants to end her life
Chile's President Michelle Bachelet on Saturday visited a 14-year-old girl suffering from cystic fibrosis who made a heart-wrenching video appeal to be allowed to end her life. Valentina Maureira had addressed Bachelet personally in the message, which she recorded with a smartphone and uploaded to YouTube from her hospital bed without her parents knowledge. Maureira is in "stable" condition from cystic fibrosis, an incurable genetic disorder that attacks the lungs and other vital organs, making it difficult to breath and causing a host of other symptoms. Her message has been viewed thousands of times on social networks, igniting debate over euthanasia in Chile, where it is forbidden by law.
Sierra Leone vice president places himself in Ebola quarantine
Sierra Leone's Vice President Samuel Sam-Sumana said on Saturday that he had placed himself in a 21-day quarantine after one of his bodyguards died of Ebola amid a worrying recent surge in new infections in the West African nation. Cases of Ebola, which has killed nearly 10,000 people in Sierra Leone, Liberia and Guinea during a year-long epidemic, have fallen off sharply in recent weeks. Of 99 new confirmed Ebola cases in the region during the week to Feb. 22, however, 63 were in Sierra Leone according to the World Health Organization's weekly report. Sam-Sumana's bodyguard John Koroma died early this week.
Herbalife cuts pay of CEO Johnson 36 percent after missed targets
Herbalife Ltd cut the pay of Chief Executive Michael Johnson 36 percent for 2014 after the nutrition and weight loss company failed to meet performance goals set for him and other top executives, according to a securities filing on Friday. Herbalife said Johnson, who is also chairman, received total compensation of $6.73 million last year, down from $10.5 million in 2013, mainly because he did not receive the incentive plan compensation of $3.7 million he got the prior year. Herbalife has been closely watched since activist investor William Ackman accused the company of running a pyramid scheme in 2012, while rival investor Carl Icahn became the company's biggest owner in 2013. Herbalife, being investigated by state and federal regulators, has denied Ackman's charges.
China says to implement drug distribution reforms
China said on Saturday it would implement drug distribution reforms including centralization measures designed to cut prices and reduce corruption. The State Council, China's cabinet, said it urged drug manufacturers to negotiate directly with hospitals on payment for pharmaceuticals instead of going through middle men. Authorities should also work to ensure the distribution of drugs to remote rural areas with underdeveloped modes of transportation in a timely fashion, the State Council said on its website. Authorities should push forward centralization and standardization measures in an effort to weed out corruption and lower prices, it added.
Singapore's Lee Kuan Yew remains in intensive care, health improves slightly
Lee Kuan Yew, Singapore's first prime minister, remains in intensive care after being admitted to hospital with severe pneumonia but his condition has improved slightly, the government said on Saturday. Lee, who turned 91 last September, has been in hospital since Feb. 5. "Lee Kuan Yew's condition has improved slightly. He remains sedated and on mechanical ventilation in the ICU (intensive care unit)," said a statement from the office of the current prime minister, adding that Lee was continuing with his antibiotics.
U.S., Liberia kick off trial of Ebola drug ZMapp
By Reuters Staff CHICAGO (Reuters) - U.S. and Liberian researchers have started a clinical trial to test the safety and effectiveness of Mapp Biopharmaceutical Inc's Ebola drug ZMapp, an experimental treatment that has already been tried in a handful of Ebola patients, including two U.S. missionaries. The trial, a joint effort by the Liberian government and the National Institute of Allergy and Infectious Diseases (NIAID), will be conducted in Liberia and the United States among adults and children infected with Ebola, NIAID said on Friday.
Doctors should take lead in push to curb climate change: experts
By Kyle Plantz LONDON (Thomson Reuters Foundation) - Doctors should take the lead in supporting political efforts to cut the pace of climate change and encouraging more people to see the problem as a crucial issue for public health, experts say. With the 68th World Health Assembly coming up in May in Geneva, countries are poised to adopt the world's first resolution on air pollution and health, in an effort to reduce premature deaths linked to air pollution. Studies have found that air pollution can worsen a variety of health problems, from heart disease to strokes, said Carlos Dora, coordinator of public health and the environment at the World Health Organization (WHO).
U.S. judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies
A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn drug Nexium and the antiviral Valcyte, a court document showed. Judge Beryl Howell of the United States District Court for the District of Colombia on Friday also blocked Ranbaxy's plea for a preliminary injunction to halt Teva Pharmaceutical Industries Ltd, Endo International Plc and Dr Reddy's Laboratories Ltd from launching copies of the two drugs. The court decision came after Ranbaxy sued the U.S. Food and Drug Administration in November for pulling approvals that would have allowed the Indian firm to launch the first copies of Roche's Valcyte and AstraZeneca Plc's Nexium. FDA had said its earlier decision granting the approvals was "in error" as Ranbaxy's plants at the time were not compliant with the U.S. regulator's manufacturing quality standards.
U.S. border officials seize record 15 tons of pot at California border
U.S. customs officers at a California border crossing seized more than 15 tons of marijuana hidden inside a tractor-trailer shipment designated as a cargo of mattresses, the biggest narcotics bust ever at that port of entry, officials said on Friday.